Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.1050
0.00 (0.00%)
Jul 3, 2026, 3:59 PM EST
Ventripoint Diagnostics Market Cap
Ventripoint Diagnostics has a market cap or net worth of CAD 20.06 million as of July 2, 2026. Its market cap has decreased by -18.16% in one year.
Market Cap
20.06M
Enterprise Value
22.61M
Revenue
179.93K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since September 21, 2007, Ventripoint Diagnostics's market cap has increased from 6.82M to 20.06M, an increase of 193.88%. That is a compound annual growth rate of 5.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 20.06M | -14.86% |
| Dec 31, 2025 | 23.56M | 45.40% |
| Dec 31, 2024 | 16.20M | -64.98% |
| Dec 29, 2023 | 46.26M | 9.26% |
| Dec 30, 2022 | 42.34M | -21.10% |
| Dec 31, 2021 | 53.67M | 567.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theralase Technologies | 81.31M |
| Cannabix Technologies | 66.34M |
| Perimeter Medical Imaging AI | 43.73M |
| Cheelcare | 35.83M |
| Conavi Medical | 23.80M |
| Aurora Spine | 19.91M |
| MedX Health | 18.04M |
| VVT Med | 16.70M |